China Biologic Products, Inc. (CBPO) Tops Q1 EPS by 5c, Revenues Beat Expectations
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Join SI Premium – FREE
China Biologic Products, Inc. (NASDAQ: CBPO) reported Q1 non-GAAP EPS of $0.31, $0.05 better than the analyst estimate of $0.26. Revenue for the quarter came in at $34.5 million versus the consensus estimate of $29.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
